Displaying 13 - 24 of 55
Viral Hepatitis
5

Gilead: "Headlines In Hepatitis Delta: The Latest Advances In Care in Hepatitis Delta" - EASL Congress 2023

View
Viral Hepatitis
3

Gilead: “From Headlines To The Clinic: Expert Approaches To Patient Care in Hepatitis Delta” - EASL Congress 2023

View
Viral Hepatitis
3

Gilead: “From Headlines To The Clinic: Expert Approaches To Patient Care in Hepatitis Delta” - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Displaying 13 - 24 of 55